Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $4,855,355.00 in Stock

Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $4,855,355.00 in Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the business's stock in a transaction on Monday, August 31st. The shares were sold at an average price of $511.09, for a total transaction of $4,855,355.00. Following the sale, the chief executive officer directly owned 324,443 shares in the company, valued at approximately $165,819,572.87. This trade represents a 2.84% decrease in their ow…

United Therapeutics (NASDAQ:UTHR) Trading Down 4.7% on Insider Selling

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) fell 4.7% during trading on Wednesday following insider selling activity. The company traded as low as $491.22 and last traded at $488.7910. Approximately 186,876 shares traded hands during trading, a decline of 62% from the average daily volume of 486,966 shares. The stock had previously closed at […]